Longevity advocate Bryan Johnson ditches rapamycin over side effects
2 Articles
2 Articles
Longevity advocate Bryan Johnson ditches rapamycin over side effects
Tech entrepreneur and longevity advocate Bryan Johnson has discontinued his use of rapamycin, a controversial anti-ageing drug, after concerns it may have accelerated ageing rather than reversed it. The 47-year-old millionaire, known for spending $2 million annually on cutting-edge treatments to slow ageing, revealed in a social media post that his team concluded the risks of lifelong rapamycin use outweighed its benefits. Johnson, who undertook…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage